| Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019 E Nichols, JD Steinmetz, SE Vollset, K Fukutaki, J Chalek, F Abd-Allah, ... The Lancet Public Health 7 (2), e105-e125, 2022 | 1886 | 2022 |
| Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis … JD Steinmetz, RRA Bourne, PS Briant, SR Flaxman, HRB Taylor, ... The Lancet Global Health 9 (2), e144-e160, 2021 | 1298 | 2021 |
| Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study R Bourne, JD Steinmetz, S Flaxman, PS Briant, HR Taylor, S Resnikoff, ... The Lancet global health 9 (2), e130-e143, 2021 | 650 | 2021 |
| Five insights from the global burden of disease study 2019 CJL Murray, C Abbafati, KM Abbas, M Abbasi, M Abbasi-Kangevari, ... The Lancet 396 (10258), 1135-1159, 2020 | 584 | 2020 |
| Hearing loss prevalence and years lived with disability, 1990–2019: findings from the Global Burden of Disease Study 2019 LM Haile, K Kamenov, PS Briant, AU Orji, JD Steinmetz, A Abdoli, ... The Lancet 397 (10278), 996-1009, 2021 | 567 | 2021 |
| Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 KL Ong, LK Stafford, SA McLaughlin, EJ Boyko, SE Vollset, AE Smith, ... The Lancet 402 (10397), 203-234, 2023 | 535 | 2023 |
| Global, regional, and national burden of bone fractures in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019 AM Wu, C Bisignano, SL James, GG Abady, A Abedi, E Abu-Gharbieh, ... The Lancet Healthy Longevity 2 (9), e580-e592, 2021 | 423 | 2021 |
| The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 KB Tran, JJ Lang, K Compton, R Xu, AR Acheson, HJ Henrikson, ... The Lancet 400 (10352), 563-591, 2022 | 406 | 2022 |
| Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global … KR Paulson, AM Kamath, T Alam, K Bienhoff, GG Abady, J Abbas, ... The Lancet 398 (10303), 870-905, 2021 | 315 | 2021 |
| Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020 D Bryazka, MB Reitsma, MG Griswold, KH Abate, C Abbafati, ... The Lancet 400 (10347), 185-235, 2022 | 244 | 2022 |
| Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 R Sharma, M Abbasi-Kangevari, R Abd-Rabu, H Abidi, E Abu-Gharbieh, ... The lancet Gastroenterology & hepatology 7 (7), 627-647, 2022 | 236 | 2022 |
| Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026 AE Micah, K Bhangdia, IE Cogswell, D Lasher, B Lidral-Porter, ... The Lancet Global Health 11 (3), e385-e413, 2023 | 131 | 2023 |
| Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019 JL Ward, PS Azzopardi, KL Francis, JS Santelli, V Skirbekk, SM Sawyer, ... The Lancet 398 (10311), 1593-1618, 2021 | 129 | 2021 |
| The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019 EM Alvarez, LM Force, R Xu, K Compton, D Lu, HJ Henrikson, ... The Lancet Oncology 23 (1), 27-52, 2022 | 122 | 2022 |
| Societal perspectives on the role of community pharmacists and over-the-counter drugs in Jordan M Wazaify, A Al-Bsoul-Younes, E Abu-Gharbieh, L Tahaineh Pharmacy world & science 30, 884-891, 2008 | 115 | 2008 |
| Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019 H Ebrahimi, Z Aryan, SS Moghaddam, C Bisignano, S Rezaei, F Pishgar, ... The Lancet Respiratory Medicine 9 (9), 1030-1049, 2021 | 111 | 2021 |
| The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the … F Kamangar, D Nasrollahzadeh, S Safiri, SG Sepanlou, C Fitzmaurice, ... The lancet Gastroenterology & hepatology 5 (6), 582-597, 2020 | 109 | 2020 |
| Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019 HH Kyu, A Vongpradith, SB Sirota, A Novotney, CE Troeger, MC Doxey, ... The Lancet infectious diseases 22 (11), 1626-1647, 2022 | 106 | 2022 |
| Impact of phenolic composition on hepatoprotective and antioxidant effects of four desert medicinal plants NG Shehab, E Abu-Gharbieh, FA Bayoumi BMC complementary and alternative medicine 15, 1-12, 2015 | 98 | 2015 |
| Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990–2019: results from the Global Burden of Disease Study 2019 JR Ledesma, J Ma, A Vongpradith, ER Maddison, A Novotney, MH Biehl, ... The lancet infectious diseases 22 (2), 222-241, 2022 | 89 | 2022 |
Fabrizio De PontiProfessor of Pharmacology, University of BolognaVerificeret mail på unibo.it
